UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 69

Sortiert nach

X-ray structure breakthroughs in the GPCR transmembrane region

Biochemical pharmacology, 2009-07, Vol.78 (1), p.11-20

2009

Volltextzugriff (PDF)

Use of the X-ray structure of the β2-adrenergic receptor for drug discovery. Part 2: Identification of active compounds

Bioorganic & medicinal chemistry letters, 2008-10, Vol.18 (20), p.5391-5395

2008

Volltextzugriff (PDF)

7TM X-ray structures for class C GPCRs as new drug-discovery tools. 1. mGluR5

Bioorganic & medicinal chemistry letters, 2016-01, Vol.26 (2), p.484-494

2016

Volltextzugriff (PDF)

The role of experimental and computational structural approaches in 7TM drug discovery

Expert opinion on drug discovery, 2015-10, Vol.10 (10), p.1071-1084

2015

Volltextzugriff (PDF)

Use of the X-ray structure of the Beta2-adrenergic receptor for drug discovery

Bioorganic & medicinal chemistry, 2008-03, Vol.18 (5), p.1598-1602

2008

Volltextzugriff (PDF)

Identification and Characterization of Small‐Molecule Ras Modulators and their Impact in Cancer Drug Discovery

The FASEB journal, 2020-04, Vol.34 (S1), p.1-1

2020

Volltextzugriff (PDF)

Design and biological characterization of a series of dual mechanism ERK1/2 inhibitors with a Triazolopyridinone core

Chemical biology & drug design, 2023-04, Vol.101 (4), p.837-847

2023

Volltextzugriff (PDF)

Structural and Conformational Requirements for High-Affinity Binding to the SH2 Domain of Grb2

Journal of medicinal chemistry, 1999-03, Vol.42 (6), p.971-980

1999

Volltextzugriff (PDF)

Exploration of structure-based drug design opportunities for mGluRs

Neuropharmacology, 2011, Vol.60 (1), p.93-101

2011

Volltextzugriff (PDF)

Antagonists for Constitutively Active Mutant Estrogen Receptors: Insights into the Roles of Antiestrogen-Core and Side-Chain

ACS chemical biology, 2018-12, Vol.13 (12), p.3374-3384

2018

Volltextzugriff (PDF)

Tricyclic Thiazolopyrazole Derivatives as Metabotropic Glutamate Receptor 4 Positive Allosteric Modulators

Journal of medicinal chemistry, 2011-07, Vol.54 (14), p.5070-5081

2011

Volltextzugriff (PDF)

Use of the X-ray structure of the beta sub(2)-adrenergic receptor for drug discovery. Part 2: Identification of active compounds

Bioorganic & medicinal chemistry, 2008-10, Vol.18 (20), p.5391-5395

2008

Volltextzugriff (PDF)

Design and Synthesis of Potent and Selective Inhibitors of Integrin VLA-4

Bioorganic & medicinal chemistry letters, 2001-11, Vol.11 (22), p.2955-2958

2001

Volltextzugriff (PDF)

4-(1-Phenyl-1H-pyrazol-4-yl)quinolines as novel, selective and brain penetrant metabotropic glutamate receptor 4 positive allosteric modulators

Bioorganic & medicinal chemistry letters, 2012-05, Vol.22 (9), p.3235-3239

2012

Volltextzugriff (PDF)

Use of the X-ray structure of the β 2-adrenergic receptor for drug discovery. Part 2: Identification of active compounds

Bioorganic & medicinal chemistry letters, 2008, Vol.18 (20), p.5391-5395

2008

Volltextzugriff (PDF)

cis-1-Oxo-heterocyclyl-4-amido cyclohexane derivatives as NPY5 receptor antagonists

Bioorganic & medicinal chemistry letters, 2014-03, Vol.24 (6), p.1458-1461

2014

Volltextzugriff (PDF)

Depletion of methionine aminopeptidase 2 does not alter cell response to fumagillin or bengamides

Cancer research (Chicago, Ill.), 2004-05, Vol.64 (9), p.2984-2987

2004

Volltextzugriff (PDF)

1,4-Diazepane-2,5-diones as novel inhibitors of LFA-1

Bioorganic & medicinal chemistry letters, 2005-02, Vol.15 (4), p.1217-1220

2005

Volltextzugriff (PDF)

Homology Modeling of the Serotonin Transporter: Insights into the Primary Escitalopram-binding Site

ChemMedChem, 2007-06, Vol.2 (6), p.815-826

2007

Volltextzugriff (PDF)

Use of the X-ray structure of the beta2-adrenergic receptor for drug discovery. Part 2: Identification of active compounds

Bioorganic & medicinal chemistry letters, 2008-10, Vol.18 (20), p.5391-5395

2008

Volltextzugriff (PDF)

Development of an aequorin luminescence calcium assay for high-throughput screening using a plate reader, the LumiLux

Assay and drug development technologies, 2008-12, Vol.6 (6), p.787

2008

Volltextzugriff (PDF)

1,4-Diazepane-2-ones as novel inhibitors of LFA-1

Bioorganic & medicinal chemistry letters, 2003-02, Vol.13 (3), p.499-502

2003

Volltextzugriff (PDF)

Recognition of cholinergic agonists by the muscarinic receptor. 1. Acetylcholine and other agonists with the NCCOCC backbone

Journal of medicinal chemistry, 1983-06, Vol.26 (6), p.817-823

1983

Volltextzugriff (PDF)

Theoretical studies of borepin and cycloheptatriene

Journal of the American Chemical Society, 1982-07, Vol.104 (14), p.3785-3788

1982

Volltextzugriff (PDF)

Computational chemical studies of chiral stationary phase models : Complexes of methyl N-(2-naphthyl)alaninate with N-(3,5-dinitrobenzoyl)leucine n-propylamide

Journal of Chromatography A, 1989, Vol.461, p.129-137

1989

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Aktive Filter

KollektionNexis

Zeitschrift / SerieBlood

ThemaExact Sciences And Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(65)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

X-ray structure breakthroughs in the GPCR transmembrane region

Use of the X-ray structure of the β2-adrenergic receptor for drug discovery. Part 2: Identification of active compounds

7TM X-ray structures for class C GPCRs as new drug-discovery tools. 1. mGluR5

The role of experimental and computational structural approaches in 7TM drug discovery

Use of the X-ray structure of the Beta2-adrenergic receptor for drug discovery

Identification and Characterization of Small‐Molecule Ras Modulators and their Impact in Cancer Drug Discovery

Design and biological characterization of a series of dual mechanism ERK1/2 inhibitors with a Triazolopyridinone core

Structural and Conformational Requirements for High-Affinity Binding to the SH2 Domain of Grb2

Exploration of structure-based drug design opportunities for mGluRs

Antagonists for Constitutively Active Mutant Estrogen Receptors: Insights into the Roles of Antiestrogen-Core and Side-Chain

Tricyclic Thiazolopyrazole Derivatives as Metabotropic Glutamate Receptor 4 Positive Allosteric Modulators

Use of the X-ray structure of the beta sub(2)-adrenergic receptor for drug discovery. Part 2: Identification of active compounds

Design and Synthesis of Potent and Selective Inhibitors of Integrin VLA-4

4-(1-Phenyl-1H-pyrazol-4-yl)quinolines as novel, selective and brain penetrant metabotropic glutamate receptor 4 positive allosteric modulators

Use of the X-ray structure of the β 2-adrenergic receptor for drug discovery. Part 2: Identification of active compounds

cis-1-Oxo-heterocyclyl-4-amido cyclohexane derivatives as NPY5 receptor antagonists

Depletion of methionine aminopeptidase 2 does not alter cell response to fumagillin or bengamides

1,4-Diazepane-2,5-diones as novel inhibitors of LFA-1

Homology Modeling of the Serotonin Transporter: Insights into the Primary Escitalopram-binding Site

Use of the X-ray structure of the beta2-adrenergic receptor for drug discovery. Part 2: Identification of active compounds

Development of an aequorin luminescence calcium assay for high-throughput screening using a plate reader, the LumiLux

1,4-Diazepane-2-ones as novel inhibitors of LFA-1

Recognition of cholinergic agonists by the muscarinic receptor. 1. Acetylcholine and other agonists with the NCCOCC backbone

Theoretical studies of borepin and cycloheptatriene

Computational chemical studies of chiral stationary phase models : Complexes of methyl N-(2-naphthyl)alaninate with N-(3,5-dinitrobenzoyl)leucine n-propylamide

Aktive Filter

Suchergebnisse filtern